A
AxoGen, Inc.
AXGN · NASDAQ · Healthcare · 2.6B
Closing price
$36.13
-0.14% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
12.9×
Enterprise value / EBITDAEV/EBITDA
8832.7×
Free cash flow yieldFCF yield
-0.2%
Return on equityROE
-12.2%
Operating margin
-3.5%
Net debt / EBITDAbalance-sheet strength
167.1×
Interest coverage
-1.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.